Latest Articles

Story

ESPHM 2017

Here you can read and download some of the posters presented during ESPHM 2017 in Prague
Story

APVS 2017

Here you can read and download some of the posters presented during APVS 2017 in Wuhan, China

It can be of your interest
Circovirus

BOEHRINGER INGELHEIM SEES ADVANTAGES OF FRESHLY MIXED VACCINE

  • 5 minutes

Boehringer Ingelheim Animal Health has decided to remain focused on freshly mixed Porcine Circovirus type 2 (PCV2)/ Mycoplasma hyopneumoniae (M.hyo) vaccines and not follow the development of a PCV2/M.hyo ready-to-use (RTU) vaccine combination. As a consequence of this decision, the company has discontinued its PCV2/M.hyo RTU research program.